Anterior knee pain subgroups: the first step towards a personalized treatment by Selfe, James et al.
Article
Anterior knee pain subgroups: the first step towards a 
personalized treatment
Selfe, James, Janssen, Jessica, Drew, Benjamin and Dey, Paola
Available at http://clok.uclan.ac.uk/22484/
Selfe, James, Janssen, Jessica ORCID: 0000­0002­5961­2736, Drew, Benjamin and Dey, Paola 
(2018) Anterior knee pain subgroups: the first step towards a personalized treatment. Annals of 
Joint, 3 (32).  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
10.21037/aoj.2018.03.16
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
Page 1 of 9
© Annals of Joint. All rights reserved. Ann Joint 2018;3:32aoj.amegroups.com
Introduction and background
The current best evidence-based treatment method for 
patellofemoral pain (PFP) is multimodal and may include 
a mix of exercise therapy, patellar taping and bracing, 
foot orthoses and surgery (1). However, what constitutes 
multimodal therapy is not the same across research studies 
and it is often applied inconsistently in clinical practice 
(1,2). High quality empirical studies (3,4) confirm that a 
multimodal approach confers some benefits to patients 
such as improved pain, function and quality of life, in the 
short term. However, there is limited evidence to support 
the longer-term outcomes of a multimodal treatment 
approach (5-8). In view of the limited benefit and lack 
of evidence of the long-term success of the multimodal 
approach, support for the idea of subgrouping patients with 
PFP has grown in recent years, especially as this approach 
has proved effective for optimising management in other 
musculoskeletal conditions, such as, low back pain (9,10). 
Strong support for the idea of clinically subgrouping PFP 
patients and delivering targeted treatment was gained at 
the First International PFP Research Retreat (11); this was 
reinforced at the 2nd and 3rd International PFP Research 
Retreats (12,13), where it was stated that: 
“Identification of subgroups remains the ‘holy grail’ for PFP 
research.” (13)
The concept of identifying subgroups within the PFP 
population is not actually that new, however, methodological 
approaches to subgroup identification have advanced 
considerably. Holmes and Clancy in 1998 (p. 299) (14), 
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when discussing the management of PFP patients, argue that:
“an adequate classification system should aid in proper 
diagnosis and treatment of specific problems. If properly devised, 
it should also aid in the comparison of results between different 
treatment centres. In addition, it should be a system that is simple 
and useful in the clinical setting with minimal use of complicated 
imaging techniques.”
This is a statement with which we wholeheartedly 
agree, however, it can be seen (Table 1) that early attempts 
at producing such a system, including that by Holmes and 
Clancy (1998) (14) themselves, resulted in increasingly 
complex, multi-layered clinical frameworks. 
Merchant (15) proposed a classification system of 
patellofemoral disorders based on aetiology with five 
major groups: trauma; patellofemoral dysplasia; idiopathic 
chondromalacia patellae; osteochondritis dissecans; 
synovial plicae (Table 1). Thirty-eight subgroups were then 
described underneath each of these specific pathological 
conditions. Wilk et al. (16) divided patellofemoral disorders 
into eight major groups: patellar compression syndromes; 
patellar instability; biomechanical dysfunction; direct 
patellar trauma; soft tissue lesions; overuse syndromes; 
osteochondritis diseases; neurologic disorders (Table 1). 
Some of these were further subdivided to generate 
26 subgroups in total. Treatment suggestions for each of the 
eight major patellofemoral dysfunction categories were then 
briefly discussed. Holmes and Clancy (14) suggested that 
from a clinical perspective, PFP in the skeletally mature 
adult falls into three broad categories: (I) patellofemoral 
instability (19 subgroups); (II) PFP with malalignment but 
no episodes of instability (11 subgroups); and (III) PFP 
without malalignment (30 subgroups) (Table 1). In total, this 
sub-classification system yielded 60 PFP subgroups. 
In contrast to the increasing complexity of these 
frameworks, Post (17) presented a paper on the clinical 
evaluation of patellofemoral disorders which summarised 
a number of discussions held by the International 
Patellofemoral Study Group (IPSG). In this paper, a simple 
two-layer hierarchy was used to initially categorise PFP 
as “Unstable”, requiring surgical intervention or “Stable”. 
“Stable” PFP was then categorised into just three subgroups: 
extremity alignment; soft tissue mobility/flexibility; 
dynamic control (Table 1). No specific threshold data for 
allocation to a subgroup was reported, however, treatment 
advice based on expert opinion for each of these subgroups 
was presented. Witvrouw et al. (18) presented subgroups 
based on a consensus of expert opinion reached by the 
European Rehabilitation Panel (Table 1). Despite moving 
Table 1 Clinically derived rather than imaging based PFP Subgroups
Author/s (date) Subgroups
Merchant (1988) (15)  
(38 subgroups)
Trauma
Patellofemoral dysplasia
Idiopathic chondromalacia patellae
Osteochondritis dissecans
Synovial plicae
Wilk et al. (1998) (16)  
(26 subgroups)
Patellar compression syndromes
Patellar instability
Biomechanical dysfunction
Direct patellar trauma
Soft tissue lesions
Overuse syndromes
Osteochondritis diseases
Neurologic disorders
Holmes and Clancy  
(1998) (14) (60 subgroups)
Patellofemoral instability
PFP with malalignment but no 
episodes of instability 
PFP without malalignment
Post (1999) (17)  
(4 subgroups)
Unstable (surgery required)
Stable subgroups
 Extremity alignment
 Soft tissue mobility/flexibility
 Dynamic control
Witvrouw et al. (2005) (18) 
(13 subgroups)
Malalignment
 Malalignment of entire leg
 Malalignment of PF joint
 Non-muscular origin
 Muscular origin
Muscular dysfunction
 Strength deficit
 Vastus medialis obliquus 
(VMO)
 Quadriceps
 Neuromuscular dysfunction
 VMO/vastus lateralis 
timing dysfunction
 Flexibility
 Hamstrings, quadriceps, 
gastrocnemius, iliotibial 
band
Table 1 (continued)
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Table 1 (continued)
Author/s (date) Subgroups
Selhorst et al. (2015) (19) 
(4 subgroups)
Elevated fear avoidance
Decreased muscle flexibility
Functional malalignment
Decreased muscle strength 
Keays et al. (2015) (20)  
(4 subgroups)
Hypermobility
Hypomobility
Faulty movement pattern
Osteoarthritis 
Selfe et al. (2016) (21)  
(3 subgroups)
Strong
Weak and tight
Weak and pronated
Drew et al. (2018) (22)  
(4 subgroups)
Strong
Pronation and malalignment
Weak
Flexible
back towards increasing complexity, this paper represents 
a bridge with the more recent efforts to understand 
subgroups. There were some attempts to define threshold 
data to guide subgroup allocation and evidence-based 
treatment recommendations for each of the subgroups were 
presented. However, the proposed thresholds were based on 
clinical observation and review of the literature rather than 
being statistically derived. Other studies have investigated 
subgroups within the PFP population using specialised high 
cost equipment not routinely seen in clinical scenarios, e.g., 
radiographic examination and scintigraphy (23), dynamic 
magnetic resonance imaging (MRI) (24,25), and six camera 
three-dimensional motion analysis systems (26). Translation 
of the results of these types of studies, using complex 
equipment, into routine clinical practice has been extremely 
limited. More recently, Selhorst et al. (19) reported on a 
pilot study of 21 paediatric patients with a mean age of 
14 years old and Keays et al. (20) reported on a study of 41 
patients that had a very wide age range from 13 to 82 years, 
with only eight patients in the young adult (20–40 years) age 
range. Interestingly, both papers described four subgroups 
of PFP patients, which appear to partially overlap (Table 1).
Few studies in PFP have had a hypothesis-driven 
approach initially using data to identify clinically important 
subgroups and then going on to explore the prognostic effect 
attributed to subgroup membership (27). Selfe et al. (21) 
and Drew et al. (22) are exceptions to this and both 
studies have based their approaches on rigorous statistical 
methods. In the case of Selfe et al. (21), this has led to the 
development of a robust simple hierarchical algorithm. This 
algorithm uses objective data generated by low cost clinical 
assessment tests to categorise patients into 1 of 3 subgroups. 
Due to the low-cost nature of the clinical assessment tests 
employed, this approach has high clinical utility. This 
makes it potentially viable for widespread future roll out 
into primary care and physiotherapy clinics, both in the 
UK and internationally, and conforms to the views of 
Holmes and Clancy (14) discussed earlier. Drew et al. (22) 
have developed this further and combined known imaging 
features with other clinical features to explore subgroups 
using established modifiable clinical, biomechanical and 
imaging features. The justification for and approaches used 
by both these studies to derive subgroups are discussed in 
more detail in the subsequent sections of this review. review. 
The Post (17) and the four more recent papers (19-22) describe 
just three or four subgroups which significantly improves 
their clinical utility. Interestingly although they employ 
differing methodologies and include slightly different 
populations there are some notable areas of overlap in the 
proposed subgroups, with all five papers identifying a tight/
hypomobile subgroup. Three papers describe separate 
subgroups where there is (I) decreased strength (19,21,22) 
or (II) decreased dynamic control/faulty movement patterns 
(17,19,20). Two papers describe separate subgroups that are 
(I) strong; or (II) have increased pronation (21,22).
Recent frameworks for subgrouping studies demonstrate 
why many of the attempts to subgroup patients in PFP have 
not translated well into clinical practice. The PROGRESS 
partnership provides some broad recommendations and 
the Medical Research Council provides a framework on 
development, design and analysis in stratification research 
(28,29). Both suggest a similar pathway from an initial 
hypothesis setting stage, which defines the problem and 
population. This then progresses to identifying the variables 
to define subgroups, understanding of the properties of the 
test, through to studies to identify the subgroups. Once 
subgroups are identified, this is followed by verification and 
validation and then robust evaluation of the effectiveness 
of subgrouping on outcome in clinical practice. As shown 
above, few previous studies have been hypothesis and data 
driven and, as yet, those that have applied this approach 
are not mature enough along the pathway to be tested in 
practice (21,22)
While these frameworks outline considerations for 
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the researcher at each stage, they do not provide clear 
recommendations on which statistical approach, for 
model prediction to identify subgroups is best in different 
circumstances (30). This is clearly an issue for the 
researcher when different methods can give different results 
with the same dataset and, thus, may identify different 
subgroups. This problem is compounded in this field as 
some techniques, such as regression methods, require 
large datasets, which are uncommon in PFP research. 
Furthermore, their outputs may be difficult to interpret 
clinically, particularly, for “theragnostic” markers (29), i.e., 
those that aim to identify which patients will respond to 
different treatments. Latent profile analysis approaches 
are increasingly considered as better analytically than 
more traditional hierarchical clustering models (31). This 
is because they are based directly on the distributional 
properties of the relevant variables. However, hierarchical 
models reflect better the clinical decision-making process 
around which treatments to choose for which patients. 
An important issue stressed in both the PROGRESS 
recommendations and the MRC framework is the 
consideration throughout development, design and analysis 
of the clinical relevance and appropriateness of the marker, 
especially if the purpose of the identification of subgroups is 
to optimise current treatment (28,29). Researchers need to 
ensure early and continuing consideration of the feasibility 
and acceptability of implementing both the test and the 
treatment for both patients and for health professionals. 
This might help direct the choice of tests, number of 
subgroups to identify, analytical approaches, thresholds for 
allocation of patients to subgroups and evaluation methods 
and outcomes.
Subgroup derived targeted intervention for 
patellofemoral pain (TIPPs)
The TIPPs programme of work (21,32) has to date 
consisted of three phases in order to identify and validate 
potential subgroups within the PFP population using 
readily available, low cost, easy to use tools found in clinical 
practice:
(I) Literature search to identify appropriate low-cost 
clinical assessments, linked to reported thresholds 
to identify clinically relevant subgroups; mapped to 
credible evidence-based treatment interventions; 
(II) Feasibility study to investigate if these assessments 
could be performed in routine clinical practice, if 
they could identify clinically relevant subgroups 
and what the optimum test thresholds for subgroup 
allocation might be within a UK population; 
(III) Validation study of the subgroups in a Turkish 
population using the same assessment protocol.
Future work will aim to identify if these subgroups of 
patients with PFP respond better to specifically targeted 
exercises compared to best evidence usual care. 
Phase 1 included an in-depth literature search to identify 
assessments that were, or could be, used in clinical practice 
and that had the potential to identify possible subgroups. 
One of the key documents guiding this phase of our 
work was the First International PFP Research Retreat 
(11). This consensus proposed three subgroups based on 
the anatomical region thought to be responsible for the 
problem, i.e., proximal, local and distal. In order to facilitate 
implementation into clinical settings, assessments were 
deemed appropriate when they were: based on evidence 
of diagnostic performance; applicable to be used in a wide 
range of clinical settings; easy to learn and administer; 
free to use or available at a low cost; linked to reported 
thresholds; linked to a credible evidence-based treatment 
intervention. Through this literature review, seven 
assessments were identified, which were all applied in the 
next phase of the programme (Table 2). 
In the phase 2 feasibility study, four National Health 
Service (NHS) physiotherapy clinics, serving the general 
population, in the UK recruited 130 people with PFP over 
a one-and-a-half-year period. This was to investigate if the 
assessments could be performed in routine clinical practice, 
if they could identify clinically relevant subgroups and to 
establish what the optimum test thresholds for subgroup 
allocation might be within a UK population. Participants 
were between 18 and 40 years old, experienced uni- or bi-
lateral PFP for at least 3 months, and had not yet started 
physiotherapy treatment. Additional study details and 
eligibility criteria are presented in (21,32).
Participants completed demographic, clinical, and 
psychosocial questionnaires related to aspects of PFP and 
were clinically assessed using the seven tests. Baseline 
demographics, such as, gender distribution and age, were 
in line with those reported by others (4,37). This study 
also identified an average wait time of almost 4 years 
for people with PFP symptoms before they consulted a 
physiotherapist. A causal pathway diagram, based on the 
broader literature review, specific consensus documents 
and expert opinion around the proximal, local and distal 
subgroups was drawn up to inform the analytical approach. 
Both hierarchical agglomerative cluster analysis and latent 
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profile analysis were used to explore the existence of 
subgroups within the sample. Surprisingly, the Hamstrings 
length test mean scores (36) were similar across all three 
subgroups identified by preliminary analyses and was 
excluded from further analysis. Three subgroups were 
found: “weak and tight” (39% of participants), “weak and 
pronated” (39%), and “strong” (22%). The two largest 
subgroups were both classified as having weak quadriceps 
and hip abductor muscles; these subgroups might benefit 
from strengthening exercises. In addition to being weak, the 
people with PFP in the “weak and pronated” subgroup had 
a significantly higher mean Foot Posture Index (FPI) than 
the other two groups. This weak and pronated subgroup 
had a FPI with a mean greater than 6; we would set this as 
the threshold for subgroup allocation as a FPI of 6 or more 
is clinically relevant for treatment needs. Therefore, in 
addition to strengthening exercises prescribing a correcting 
foot orthotic to people meeting this criteria in the “weak 
and pronated group” might also be beneficial. 
Both weak subgroups were consistent with current 
treatment practices for PFP (1,2). The third identified 
subgroup (“strong”) is a novel previously unrecognised group 
that falls outside the current treatment recommendations 
as no weakness in strength or shortening in muscle length 
was identified. The people in this subgroup also experienced 
higher levels of function and quality-of-life. It is currently 
our hypothesis that this group is overloading their 
patellofemoral joint due to reduced motor control therefore 
perhaps proprioceptive training is the answer for improving 
their PFP. There is evidence to suggest motor control of 
the quadriceps may be problematic in some PFP patients 
(4,18,38,39), therefore neuromuscular retraining could be the 
focus of any rehabilitation strategy rather than strengthening 
exercises for this subgroup of patients. Recently Greuel 
et al. (40) have independently confirmed the existence of 
a strong group of PFP patients. They reported that there 
were no differences in strength between healthy subjects 
and a strong group of PFP patients. However, they reported 
an increased level of muscle inhibition in the strong PFP 
patients, suggestive of a motor control problem. The efficacy 
of these proposed treatments need to be demonstrated in a 
randomised controlled trial (RCT). 
Phase 3 aimed to validate the findings of phase 2 in a 
different population. In Turkey, an identical TIPPs study 
was set up exploring subgroups in the PFP population. 
Forty-six participants took part and underwent the six 
assessments, which were demonstrated as useful in phase 2 
of the UK study. Publication of the findings of this study 
will strengthen the evidence for the three subgroups. An 
interesting consideration is the potential for different 
distributions of subgroups in different populations; this 
raises the possibility of environmental or genetic influencing 
factors in some subgroups and/or different norms, which 
might have an impact on subgroup thresholds. 
Currently, it is still unknown if targeted treatment of the 
three subgroups will lead to improved patient outcomes. 
The TIPPs programme of research presented here used 
a one-off assessment and therefore no outcome data are 
available. Future research should investigate the prognostic 
implications of these subgroups and establish the level of 
efficacy of more targeted intervention. 
PFP subgroups derived from imaging
There have been numerous attempts at classifying and 
subgrouping PFP using imaging (41). However, no consensus 
exists on which imaging modalities should be used or which 
patellofemoral joint features are associated with PFP compared 
to asymptomatic individuals (42). There is, in addition, in the 
UK a pressure to reduce imaging in clinical practice due to 
Table 2 Seven assessments mapped to the appropriate evidence-based treatment option
Assessments Treatment intervention option
Hand held dynamometry for hip abductor strength (Nm/kg) (33) Hip abductor strengthening
Hand held dynamometry for quadriceps strength (Nm/kg) (33) Quadriceps strengthening
Medial-lateral patellar mobility test (mm) (34) Patella stabilisation or mobilisation 
Foot Posture Index (FPI) (35) Foot orthotics
Rectus femoris length test (degrees) (34) Muscle stretching
Hamstrings length test (degrees) (36) Muscle stretching
Gastrocnemius length test (degrees) (34) Muscle stretching
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resource constraints, this risks the biological component of the 
biopsychosocial model being overlooked and potentially stifles 
research that can improve our understanding of how local 
joint pathology influences clinical presentation (43). A recent 
systematic review has demonstrated that a number of MRI 
features are associated with PFP, i.e., MRI bisect offset and 
CT congruence angle analysed at 0 knee flexion and 15 knee 
flexion respectively (42).
Early imaging research into subgroups was based on 
observed pathological changes within the patella with no 
demonstrable link to clinical symptoms or their potential 
to be modified through clinical interventions. One of 
the earliest examples of this type of classification is the 
five sub-types of chondromalacia patellae identified by 
Ficat et al. (44): lateral facet chondromalacia, medial 
facet chondromalacia, central chondromalacia, bipolar 
chondromalacia and total chondromalacia.
The term malalignment can be misleading as some 
authors use this term to describe differences during 
both static and dynamic observations (45). For the sake 
of clarity, here malalignment will be used to describe a 
static observation and maltracking will refer to dynamic 
assessment. Sheehan et al. (24) classified their PFP group 
into maltrackers and non-maltrackers by classifying all 
non-maltrackers with a patellofemoral lateral-medial 
displacement of ≥0.45 mm and a patellofemoral varus 
angle slope ≤0.25 mm/°. Using discriminatory analysis this 
maltracking criteria yielded a 90% agreement reinforcing 
the existence of these two subgroups (24). Employing 
the same maltracking criteria, Harbaugh et al. (25) 
explored the relationship of these maltracking and 
non-maltracking groups with quantifiable femoral and 
patella shape. They showed that compared to non PFP 
maltrackers, the maltracking subgroup showed a 20% 
smaller lateral trochlear inclination (LTI) (25). Linking 
these subgroups with femoral shape proposes an anatomical 
explanation for the observed differences in subgroups with 
the increased LTI in the non-lateral maltrackers acting as 
an osseous constraint to lateral displacement (25). This 
idea is supported by an in vitro study which showed using 
a simulated trochleoplasty (and increasing the LTI) that 
lateral patella displacement is reduced by ~2.5 mm (46). It 
is worth noting that these studies selected patients based 
on PFP plus the presence of at least one maltracking sign 
including large static Q-angle, positive apprehension test, 
positive J-sign or clinical lateral patella hypermobility 
(24,25), which may affect the generalisability of these 
findings when compared to a typical group of individuals 
with PFP. The MRI scans were also acquired in non-weight 
bearing. 
Evolving these imaging subgroups concept further, a 
series of papers by Pal and colleagues (47-49) explored 
this idea of maltracking using full weight bearing MRI. 
In contrast to the previous studies, they classified their 
maltracking PFP subgroup as being greater than the 75th 
percentile of a non-Gaussian two-parameter Weibull 
distribution model. Using gender-specific thresholds they 
showed that compared to a non-maltracking PFP group, 
a maltracking subgroup is significantly associated with a 
delay in vastus medialis (VM) activation during the normal 
gait cycle (R2 =0.89) and an increased patella height 
when measured using both the Caton-Deschamps and 
Blackburne-Peel techniques. 
The growing support for identifying PFP subgroups 
using imaging and increased understanding of how 
these groups link to other clinical features, such as, VM 
activation, offers potential treatment strategies moving 
forwards. Patella tilt has been shown to be modifiable with 
patella bracing (50) and patellofemoral bisect offset/lateral 
displacement modifiable with both patella bracing (50) 
and patella taping (51). Recently, expanding on these 
efforts to combine known imaging features with other 
clinical features, Drew et al. (22) explored subgroups 
using established modifiable clinical (hamstring length, 
quadriceps length, gastrocnemius length and foot posture), 
biomechanical (knee extension strength, hip abduction 
strength, peak knee flexion angle and peak hip internal 
rotation angle) and imaging features (MRI bisect offset and 
MRI patella tilt). They identified “Strong”, “Pronation 
& Malalignment”, “Weak” and “Flexible” subgroups. 
Furthermore, the natural prognosis of these subgroups was 
established. By adjusting for known covariates, they showed, 
compared to a “Strong” subgroup, a substantive directional 
trend that the “Weak” subgroup was the least likely [32% 
(7/22); odds ratio (OR): 0.30; 95% CI, 0.07–1.36] and the 
“Flexible” subgroup most likely [64% (7/11); OR 1.24; 95% 
CI, 0.20–7.51] to report a favourable outcome at 12 months 
follow-up. 
Conclusions
There have been many attempts at defining subgroups 
within the PFP population over the years. Post (17); 
Selhorst et al. (19); Keays et al. (20); Selfe et al. (21); Drew 
et al. (22); using quite different approaches, describe just 
three or four subgroups with some notable areas of overlap, 
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all five papers refer to a tight/hypomobile subgroup. 
Three papers describe separate subgroups where there is 
(I) decreased strength; or (II) decreased dynamic control/
faulty movement patterns. Two papers describe separate 
subgroups that are (I) strong; or (II) have increased 
pronation. Although yet to reach a consensus on the optimal 
approach, the development of robust frameworks to guide 
stratification research, sophisticated statistical modelling 
techniques and the drive towards personalised medicine 
have stimulated new efforts in subgrouping research for 
PFP, which is gathering momentum. Our experience has 
highlighted some of the challenges and opportunities in 
undertaking such subgrouping research in PFP. One is small 
sample size, which precludes many of the more complex, 
statistical methods for classifying subgroups and/or 
optimising thresholds. In the Selfe et al. (21) study, it also 
precluded cross-validation studies for internal verification 
requiring reliance on using two different statistical methods 
instead. Given sample size is a difficulty in many PFP 
studies, consideration should be given to establishing large 
prospective datasets, which may require collaboration across 
institutions and countries. Such an initiative requires a core 
dataset of putative markers, such as the tests above, but also 
others for which there may be emerging evidence of their 
prognostic impact, e.g., psychosocial factors (52) and a core 
set of outcome measures. While progress is being made 
on the latter with the development of the KOOS-PF (53) 
there remains a bewildering variety of different tests used 
to measure the same clinical phenomenon; some are more 
practical to use than others. Finally, we also need carefully 
collected normative data on key measures to allow for 
appropriate interpretation of comparative test data in PFP 
patients. To date no definitive RCTs have been conducted 
to evaluate the potential benefits of targeted interventions 
for PFP subgroups in terms of improved patient outcomes 
so this warrants further research (21,54). 
Acknowledgements 
The authors would like to thank all the patients who kindly 
volunteered to take part in these studies.
The authors thank the wider TIPPs team and specifically 
the following physiotherapists for performing the research 
assessments Steve Hill, Stephen Kirk, Gary McCall, 
Christine Dewsbury, Kim Patterson and Sophie Chatwin. 
The authors would also like to thank the following service 
managers for their support Keith Mills, Elaine Nicholls, 
Barbara Sharp, Chantel Ostler and Kim Patterson. The 
authors would also like to thank Brian Francis for his advice 
on latent profile analysis and its application. The TIPPs 
team acknowledge the support of the National Institute 
for Health Research, through the Comprehensive Clinical 
Research Network.
This work was supported by National Institute for 
Health Research (NIHR) Clinical Doctoral Research 
Fellowship (CDRF -2013-04-044); Arthritis Research UK 
(grant number 19950) and involves collaboration with 
the Arthritis Research UK Centre for Sport, Exercise and 
Osteoarthritis. Arthritis Research UK Musculoskeletal Pain 
CSG, also funded a Think Tank meeting. 
This work was also supported in part by funding from 
the Arthritis Research UK Experimental Osteoarthritis 
Treatment Centre (Ref 20083) and the Arthritis Research 
UK Centre for Sport, Exercise and Osteoarthritis (Ref 
20194).
Footnote
Conflicts of Interest: The author has no conflicts of interest to 
declare.
References
1. Barton CJ, Lack S, Hemmings S, et al. The ‘best practice 
guide to conservative management of patellofemoral 
pain’: incorporating level 1 evidence with expert clinical 
reasoning. Br J Sports Med 2015;49:923-34. 
2. Smith BE, Hendrick P, Bateman M, et al. Current 
management strategies for patellofemoral pain: an online 
survey of 99 practising UK physiotherapists. BMC 
Musculoskelet Disord 2017;18:181. 
3. Collins N, Crossley K, Beller E, et al. Foot orthoses and 
physiotherapy in the treatment of patellofemoral pain 
syndrome: randomised clinical trial. BMJ 2008;337:a1735. 
4. Syme G, Rowe P, Martin D, et al. Disability in patients 
with chronic patellofemoral pain syndrome: a randomised 
controlled trial of VMO selective training versus general 
quadriceps strengthening. Man Ther 2009;14:252-63. 
5. Crossley KM, Macri EM, Cowan SM, et al. The 
patellofemoral pain and osteoarthritis subscale of the 
KOOS (KOOS-PF): development and validation using the 
COSMIN checklist. Br J Sports Med 2017. [Epub ahead 
of print]. 
6. Whittingham M, Palmer S, Macmillan F. Effects of taping 
on pain and function in patellofemoral pain syndrome: a 
randomized controlled trial. J Orthop Sports Phys Ther 
Page 8 of 9 Annals of Joint, 2018
© Annals of Joint. All rights reserved. Ann Joint 2018;3:32aoj.amegroups.com
2004;34:504-10. 
7. Dixit S, DiFiori JP, Burton M, et al. Management of 
patellofemoral pain syndrome. Am Fam Physician 
2007;75:194-202. 
8. Blønd L, Hansen L. Patellofemoral Pain Syndrome in 
Athletes. Acta Orthopaedica Belgica 1998;64:393-400. 
9. Brennan GP, Fritz JM, Hunter SJ, et al. Identifying 
subgroups of patients with acute/subacute "nonspecific" 
low back pain: results of a randomized clinical trial. Spine 
2006;31:623-31. 
10. Hill JC, Whitehurst DG, Lewis M, et al Comparison of 
stratified primary care management for low back pain 
with current best practice (STarT Back): a randomised 
controlled trial. Lancet 2011;378:1560-71. 
11. Davis IS, Powers CM. Patellofemoral pain syndrome: 
proximal, distal, and local factors, an international retreat, 
April 30-May 2, 2009, Fells Point, Baltimore, MD. J 
Orthop Sports Phys Ther 2010;40:A1-16. 
12. Powers CM, Bolgla LA, Callaghan MJ, et al. 
Patellofemoral pain: proximal, distal, and local factors, 
2nd International Research Retreat. J Orthop Sports Phys 
Ther 2012;42:A1-54. 
13. Witvrouw E, Callaghan MJ, Stefanik JJ, et al. Patellofemoral 
pain: consensus statement from the 3rd International 
Patellofemoral Pain Research Retreat held in Vancouver, 
September 2014. Br J Sports Med 2014;48:411-4. 
14. Holmes SW Jr, Clancy WG Jr. Clinical classification of 
patellofemoral pain and dysfunction. J Orthop Sports Phys 
Ther 1998;28:299-306. 
15. Merchant AC. Classification of patellofemoral disorders. 
Arthroscopy 1988;4:235-40. 
16. Wilk KE, Davies GJ, Mangine RE, et al. Patellofemoral 
disorders: a classification system and clinical guidelines for 
nonoperative rehabilitation. J Orthop Sports Phys Ther 
1998;28:307-22. 
17. Post WR. Current Concepts Clinical Evaluation of 
Patients With Patellofemoral Disorders. Arthroscopy 
1999;15:841-51. 
18. Witvrouw E, Werner S, Mikkelsen C, et al. Clinical 
classification of patellofemoral pain syndrome: guidelines 
for non-operative treatment. Knee Surg Sports Traumatol 
Arthrosc 2005;13:122-30. 
19. Selhorst M, Rice W, Degenhart T, et al. Evaluation of 
a treatment algorithm for patients with patellofemoral 
pain syndrome: a pilot study. Int J Sports Phys Ther 
2015;10:178-88. 
20. Keays SL, Mason M, Newcombe PA. Individualized 
physiotherapy in the treatment of patellofemoral pain. 
Physiother Res Int 2015;20:22-36. 
21. Selfe J, Janssen J, Callaghan M, et al. Are there three main 
subgroups within the patellofemoral pain population? 
A detailed characterisation study of 127 patients to help 
develop targeted intervention (TIPPs). Br J Sports Med 
2016;50:873-80. 
22. Drew BT, Conaghan PG, Smith TO, et al. Development 
of data-driven diagnostic subgroups for people 
with patellofemoral pain using modifiable clinical, 
biomechanical and imaging features. 14th Scandinavian 
Congress of Medicine & Science in Sports, 31 January–02 
February 2018; Copenhagen, Denmark. Sports Kongres 
2018 App. Available online: http://www.sportskongres.dk/
index.html
23. Näslund J, Näslund UB, Odenbring S, et al. Comparison 
of symptoms and clinical findings in subgroups of 
individuals with patellofemoral pain. Physiother Theory 
Pract 2006;22:105-18. 
24. Sheehan FT, Derasari A, Fine KM, et al. Q-angle and J-sign: 
indicative of maltracking subgroups in patellofemoral pain. 
Clin Orthop Relat Res 2010;468:266-75. 
25. Harbaugh CM, Wilson NA, Sheehan FT. Correlating 
femoral shape with patellar kinematics in patients with 
patellofemoral pain. J Orthop Res 2010;28:865-72. 
26. Dierks TA, Manal KT, Hamill J, et al. Lower extremity 
kinematics in runners with patellofemoral pain during a 
prolonged run. Med Sci Sports Exerc 2011;43:693-700. 
27. Kent P, Keating JL, Leboeuf-Yde C. Research methods 
for subgrouping low back pain. BMC Med Res Methodol 
2010;10:62. 
28. Hingorani AD, van der Windt DA, Riley RD, et al. 
Prognosis research strategy (PROGRESS) 4: stratified 
medicine research. BMJ 2013;346:e5793. 
29. MRC. The MRC framework for the development, design 
and analysis of stratified medicine research. Available 
online: https://www.mrc.ac.uk/publications/browse/mrc-
framework-for-stratified-medicine/
30. Everitt BS, Landau S, Leese M, et al. Cluster analysis 
(Wiley series in probability and statistics). 5th edition. 
John Wiley and Sons, 2011.
31. Hagenaars JA, McCutcheon AL. Applied latent class analysis. 
Cambridge, NY: Cambridge University Press, 2002.
32. Selfe J, Callaghan M, Witvrouw E, et al. Targeted 
interventions for patellofemoral pain syndrome 
(TIPPS): classification of clinical subgroups. BMJ Open 
2013;3:e003795. 
33. Maffiuletti NA. Assessment of hip and knee muscle 
function in orthopaedic practice and research. J Bone Joint 
Page 9 of 9Annals of Joint, 2018
© Annals of Joint. All rights reserved. Ann Joint 2018;3:32aoj.amegroups.com
Surg Am 2010;92:220-9. 
34. Witvrouw E, Lysens R, Bellemans J, et al. Intrinsic risk 
factors for the development of anterior knee pain in an 
athletic population. A two-year prospective study. Am J 
Sports Med 2000;28:480-9. 
35. Redmond AC, Crane YZ, Menz HB. Normative values for 
the Foot Posture Index. J Foot Ankle Res 2008;1:6. 
36. Youdas JW, Krause DA, Hollman JH, et al. The influence 
of gender and age on hamstring muscle length in healthy 
adults. J Orthop Sports Phys Ther 2005;35:246-52. 
37. Brown J. Physiotherapists Knowledge of Patellofemoral 
Pain Syndrome. British Journal of Therapy and 
Rehabilitation 2000;7:346-53.
38. Callaghan MJ, Selfe J, McHenry A, et al. Effects of patellar 
taping on knee joint proprioception in patients with 
patellofemoral pain syndrome. Man Ther 2008;13:192-9. 
39. Gallina A, Hunt MA, Hodges P, et al. Vastus lateralis 
motor unit firing rate is higher in females with 
patellofemoral pain. Arch Phys Med Rehabil 2018. [Epub 
ahead of print]. 
40. Greuel H, Herrington L, Liu A, et al. How does pain 
influence arthrogenic muscle inhibition and quadriceps 
torque in individuals with patellofemoral pain. 5th 
International Patellofemoral Research Retreat. Gold Coast 
Queensland, Australia, 2017.
41. Callaghan MJ. Will Sub-classification of Patellofemoral 
Pain Improve Physiotherapy Treatment? In: Sports 
Injuries. Berlin: Springer, 2012:571-7.
42. Drew BT, Redmond AC, Smith TO, et al. Which 
patellofemoral joint imaging features are associated with 
patellofemoral pain? Systematic review and meta-analysis. 
Osteoarthritis Cartilage 2016;24:224-36. 
43. Elliott JM, Hancock MJ, Crawford RJ, et al. Advancing 
imaging technologies for patients with spinal pain: with 
a focus on whiplash injury. Spine J 2017. [Epub ahead of 
print]. 
44. Ficat RP, Philippe J, Hungerford DS. Chondromalacia 
patellae: a system of classification. Clin Orthop Relat Res 
1979:55-62. 
45. Teitge RA, Torga-Spak R. Skeletal malalignment and 
anterior knee pain: rationale, diagnosis, and management. 
In: Sanchis-Alfonso V. editors. Anterior knee pain and 
patellar instability. Springer, 2011:209-21.
46. Amis AA, Oguz C, Bull AM, et al. The effect of 
trochleoplasty on patellar stability and kinematics: a 
biomechanical study in vitro. J Bone Joint Surg Br 
2008;90:864-9. 
47. Pal S, Draper CE, Fredericson M, et al. Patellar 
maltracking correlates with vastus medialis activation 
delay in patellofemoral pain patients. Am J Sports Med 
2011;39:590-8. 
48. Pal S, Besier TF, Draper CE, et al. Patellar tilt correlates 
with vastus lateralis: vastus medialis activation ratio in 
maltracking patellofemoral pain patients. J Orthop Res 
2012;30:927-33. 
49. Pal S, Besier TF, Beaupre GS, et al. Patellar maltracking is 
prevalent among patellofemoral pain subjects with patella 
alta: an upright, weightbearing MRI study. J Orthop Res 
2013;31:448-57. 
50. Draper CE, Besier TF, Santos JM, et al. Using real-
time MRI to quantify altered joint kinematics in subjects 
with patellofemoral pain and to evaluate the effects of a 
patellar brace or sleeve on joint motion. J Orthop Res 
2009;27:571-7. 
51. Worrell T, Ingersoll CD, Bockrath-Pugliese K, et al. 
Effect of patellar taping and bracing on patellar position as 
determined by MRI in patients with patellofemoral pain. J 
Athl Train 1998;33:16-20. 
52. Maclachlan LR, Collins NJ, Matthews MLG, et al. The 
psychological features of patellofemoral pain: a systematic 
review. Br J Sports Med 2017;51:732-42. 
53. Crossley K, Bennell K, Green S, et al. Physical therapy for 
patellofemoral pain: a randomized, double-blinded, placebo-
controlled trial. Am J Sports Med 2002;30:857-65. 
54. Drew BT, Conaghan PG, Smith TO, et al. The effect of 
targeted treatment on people with patellofemoral pain: a 
pragmatic, randomised controlled feasibility study. BMC 
Musculoskelet Disord 2017;18:338. 
doi: 10.21037/aoj.2018.03.16
Cite this article as: Selfe J, Janssen J, Drew B, Dey P. Anterior 
knee pain subgroups: the first step towards a personalized 
treatment. Ann Joint 2018;3:32. 
